In conclusion, the promise of base editing in severe progressive retinal degeneration with congenital retinal abnormalities such as CRB1 lies in its potential to address the underlying genetic mutations responsible for these conditions [67,68,69]. Here, CRB1 is linked to retinal degeneration.